Medical Membrane Market Report 2025

The medical membrane market size has grown strongly in recent years. It will grow from $3.39 billion in 2024 to $3.71 billion in 2025 at a compound annual growth rate (CAGR) of 9.5%. The growth during the historic period can be attributed to the increase in hemodialysis procedures, expansion of the medical device industry, rising incidence of chronic kidney disease, a growing number of surgeries, and the increased use of membranes in filtration and sterilization processes.

The medical membrane market size is expected to see strong growth in the next few years. It will grow to $5.27 billion in 2029 at a compound annual growth rate (CAGR) of 9.2%. The growth expected in the forecast period can be attributed to the increasing global burden of renal and cardiovascular diseases, the expanding geriatric population, a growing emphasis on point-of-care diagnostics, the surge in biopharmaceutical manufacturing capacity, and rising demand for advanced wound care solutions. Key trends during this period include advancements in membrane-based drug delivery systems, improved separation techniques for high-purity medical applications, development of personalized membrane solutions, innovations in 3D-printed medical membranes, and the creation of temperature-sensitive membrane materials.

The rising prevalence of chronic diseases is expected to drive the growth of the medical membrane market in the future. Chronic diseases are long-term health conditions that usually develop slowly and last for a year or more, often requiring continuous medical care and lifestyle adjustments. The increase in chronic diseases is linked to more sedentary lifestyles, which contribute to obesity, diabetes, and cardiovascular problems. Medical membranes play a crucial role in managing chronic diseases by enabling efficient separation, filtration, or controlled drug delivery in treatments such as dialysis, respiratory support, and implantable devices. For example, in June 2024, the National Library of Medicine, a US-based medical library, reported that the number of Americans aged 50 and older living with at least one chronic condition is expected to nearly double by 2050, reaching approximately 142.66 million - a 99.5% increase. Consequently, the growing prevalence of chronic diseases is anticipated to fuel the medical membrane market.

Leading companies in the medical membrane market are concentrating on creating innovative products like dehydrated amniotic membranes to improve wound healing effectiveness, extend shelf life, and simplify storage and handling in clinical environments. A dehydrated amniotic membrane is a preserved, dry version of the innermost placental layer used medically to promote wound healing, reduce inflammation, and support tissue regeneration. For instance, Precise Bioscience LLC, a healthcare company based in the US, launched AdvoGraft One and AdvoGraft Membrane Dual - two advanced biologic wound care products aimed at facilitating natural healing for both acute and chronic wounds. AdvoGraft One contains a single-layer dehydrated amniotic membrane, while AdvoGraft Membrane Dual includes both amniotic and chorionic layers, offering enhanced structural strength and biological activity. These membranes serve as natural barriers that encourage cellular migration and tissue regeneration, particularly for chronic and acute wounds. Both products are engineered to retain bioactivity after processing, creating optimal healing conditions while minimizing inflammation and scar tissue formation.

In September 2024, Solvita, a US-based company specializing in regenerative biomaterials, acquired the assets of Snoasis Medical LLC for an undisclosed sum. This acquisition is intended to expand Solvita’s Maxxeus portfolio, strengthen its presence in the dental regenerative solutions market, and improve its offerings in biologic membrane technologies. Snoasis Medical LLC is a US-based firm that develops placental tissue-based regenerative products for dental and oral surgery applications.

Major players in the medical membrane market are Thermo Fisher Scientific Inc., LG Chem Ltd., 3M Company, Mitsubishi Chemical Corporation, Merck KGaA, Parker-Hannifin Corporation, Toray Industries Inc., DuPont de Nemours Inc., DSM-Firmenich AG, Nitto Denko Corporation, Sartorius AG, Nipro Corporation, W. L. Gore & Associates Inc., BioTissue Inc., Advanced Microdevices Pvt. Ltd., Medica S.p.A., Koch Industries Inc., Applied Membrane Technology Inc., Theway Membranes Co. Ltd., Hollowbrane Membrane Technologies Pvt. Ltd.

North America was the largest region in the medical membrane market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in medical membrane report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the medical membrane market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The medical membrane market includes sales of dialysis membranes, filtration membranes, drug delivery membranes, and diagnostic membranes. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The medical membrane market research report is one of a series of new reports that provides medical membrane market statistics, including the medical membrane industry global market size, regional shares, competitors with the medical membrane market share, detailed medical membrane market segments, market trends, and opportunities, and any further data you may need to thrive in the medical membrane industry. This medical membrane market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

A medical membrane is a selectively permeable barrier used in healthcare to separate, filter, or transport substances such as fluids, gases, or cells. It finds applications in dialysis, drug delivery, and wound care because of its biocompatibility and its capacity to regulate molecular movement.

The primary materials used for medical membranes include polysulfone (PSU) and polyether sulfone (PESU), polyvinylidene fluoride (PVDF), hydrophobic and hydrophilic forms of polyvinylidene fluoride, polytetrafluoroethylene (PTFE), polypropylene (PP), modified acrylics, among others. Polysulfone (PSU) and polyether sulfone (PESU) are high-performance thermoplastics valued for their excellent thermal stability, chemical resistance, and broad usage in medical membranes and filtration applications. These membranes employ various technologies such as ultrafiltration, microfiltration, nanofiltration, reverse osmosis, dialysis, gas filtration, and more. They are utilized across a range of fields including pharmaceutical filtration, IV infusion and sterile filtration, bio-artificial processes, drug delivery, hemodialysis, and others.

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.